PEG-ASP, Etoposide and Gemcitabine for Natural Killer/T Lymphoma

Clinical trial NCT02705508 · UNKNOWN

Trial details

NCT number: NCT02705508
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Treatment Refusal

Start date: 2016-02-01
Primary completion: 2023-12-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.